- Bristol-Myers Squibb (NYSE:BMY) officially completed purchase of Amylin Pharmaceuticals (NASDAQ:AMLN) yesterday. The acquisition was completed without shareholder approval after BMY purchased additional AMLN shares directly … Continue Reading
Read now- Shares of drug-maker Warner Chilcott (NASDAQ:WCRX) are trading in immense volume today, nearly 5x daily average, and pushing the stock price down by 5%. The … Continue Reading
Read nowLong Ideas - The recent sharp decline in Halozyme Therapeutics (NASDAQ:HALO) last week in fact presented a major buying opportunity for investors, with the shares up roughly 57% … Continue Reading
Read nowShort Ideas - Shares of Seattle Genetics (NASDAQ:SGEN) have traded progressively higher this year, but tonight the rubber could meet the road if reported sales of lead cancer … Continue Reading
Read nowLong Ideas - Amarin’s (NASDAQ:AMRN) sell-off following the largely anticipated FDA approval of Vascepa has given investors a chance to buy the stock at an attractive valuation. However, … Continue Reading
Read now- With the announcement that Elan’s (NYSE:ELN) bapineuzumab candidate for Alzheimer’s disease failed again in a Phase III clinical trial, partners Pfizer (NYSE:PFE) and Johnson & … Continue Reading
Read now- A balloon-expandable stent system developed by Abbot Laboratories (NYSE:ABT) received FDA approval this morning for the treatment of iliac artery disease. A form of peripheral … Continue Reading
Read now